Primary Peritoneal Cavity Cancer Recruiting Phase 1 / 2 Trials for Pazopanib (DB06589)

IndicationStatusPhase
DBCOND0028458 (Primary Peritoneal Cavity Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01402271Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerTreatment